Methylation status of WWOX gene promoter CpG islands in epithelial ovarian cancer and its clinical significance

Yan,Hongchao; Sun,Jieyun

doi:10.3892/br.2013.86

Methylation status of WWOX gene promoter CpG islands in epithelial ovarian cancer and its clinical significance

Authors:
- Hongchao Yan
- Jieyun Sun
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221002, P.R. China
Published online on: March 22, 2013 https://doi.org/10.3892/br.2013.86
Pages: 375-378

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

WW domain-containing oxidoreductase (WWOX) is a newly identified tumor suppressor gene that is associated with abnormal DNA methylation. The aim of this study was to evaluate the methylation status of CpG islands in the WWOX gene promoter region in cases of epithelial ovarian cancer and explore the correlation between the methylation status of the WWOX gene CpG islands and clinicopathological indices in patients with epithelial ovarian cancer. The methylation status of the WWOX gene CpG island was evaluated by methylation‑specific polymerase chain reaction (MSP) in 48 patients with epithelial ovarian cancer, 18 patients with borderline epithelial ovarian tumors, 26 patients with epithelial benign tumors and 33 patients with normal ovarian tissues. Results showed that the rates of CpG island methylation in the WWOX gene promoter region in epithelial ovarian cancer tissues, borderline ovarian tumor tissues and benign ovarian tumor tissues were 43.75, 26.32 and 3.84%, respectively. The WWOX gene CpG islands were not methylated in normal ovarian tissues. The rate of CpG island methylation in epithelial ovarian cancer tissues was higher than that of other ovarian tissues and these differences were found to be statistically significant (P<0.01). The rate of CpG island methylation in the WWOX gene promoter region in late‑stage (stage III and IV) epithelial ovarian cancer tissues was higher than that of early‑stage (stage Ⅰ and II) epithelial ovarian cancer tissues, and these differences were found to be statistically significant (P<0.05). In conclusion, epithelial ovarian cancer tissues showed CpG island hypermethylation in the WWOX gene promoter region, which may be an important mechanism leading to WWOX gene inactivation. Atypical methylation of WWOX gene is associated with the formation and progression of epithelial ovarian cancer, rendering it a potentially important indicator in the early diagnosis and prognosis of epithelial ovarian cancer.

View Figures

View References

1	Li XQ, Guo YY and De W: DNA methylation and microRNAs in cancer. World J Gastroenterol. 18:882–888. 2012. View Article : Google Scholar : PubMed/NCBI
2	Nagarajan RP and Costello JF: Epigenetic mechanisms in glioblastoma multiforme. Semin Cancer Biol. 19:188–197. 2009. View Article : Google Scholar : PubMed/NCBI
3	Kanai Y: Alterations of DNA methylation and clinicopathological diversity of human cancers. Pathol Int. 58:544–558. 2008. View Article : Google Scholar : PubMed/NCBI
4	Bednarek AK, Laflin KJ, Daniel RL, et al: WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3–24.1, a region frequently affected in breast cancer. Cancer Res. 60:2140–2145. 2000.PubMed/NCBI
5	Iliopoulos D, Guler G, Han SY, et al: Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene. 24:1625–1633. 2005. View Article : Google Scholar : PubMed/NCBI
6	Qin HR, Iliopoulos D, Semba S, et al: A role for the WWOX gene in prostate cancer. Cancer Res. 66:6477–6481. 2006. View Article : Google Scholar : PubMed/NCBI
7	Yan J, Zhang M and Zhang J: Helicobacter pylori infection promotes methylation of WWOX gene in human gastric cancer. Biochem Biophys Res Commun. 408:99–102. 2011. View Article : Google Scholar
8	Roett MA and Evans P: Ovarian cancer: an overview. Am Fam Physician. 80:609–616. 2009.
9	Azhikina TL and Sverdlov ED: Study of tissue-specific CpG methylation of DNA in extended genomic loci. Biochemistry (Mosc). 70:596–603. 2005. View Article : Google Scholar : PubMed/NCBI
10	Surowiak P, Materna V, Maciejczyk A, et al: Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factor. Histol Histopathol. 23:531–538. 2008.PubMed/NCBI
11	Feng W, Marquez RT, Lu Z, et al: Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer. 112:1489–1502. 2008. View Article : Google Scholar : PubMed/NCBI
12	Potapova A, Hoffman AM, Godwin AK, et al: Promoter hyper-methylation of PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer. Cancer Res. 68:998–1002. 2008. View Article : Google Scholar : PubMed/NCBI
13	Makarla PB, Saboorian MH, Ashfaq R, et al: Promoter hyper-methylation profile of ovarian epithelial neoplasms. Clin Cancer Res. 11:5365–5369. 2005. View Article : Google Scholar : PubMed/NCBI
14	Yan HC, Lu XY and Han QY: WWOX mRNA expression in epithelial ovarian cancer and its clinical significance. Acta Academiae Medicinae Xuzhou. 27:126–128. 2007.(In Chinese).
15	Yan HC, Xue JQ, Lu XY, et al: Effects of WWOX gene transfection on cell growth of epithelial ovarian cancer. Zhonghua Fu Chan Ke Za Zhi. 43:361–365. 2008.(In Chinese).